nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—SLC22A5—Dactinomycin—ocular cancer	0.479	0.563	CbGbCtD
Sparfloxacin—ABCC2—Carboplatin—ocular cancer	0.251	0.294	CbGbCtD
Sparfloxacin—ABCB1—Dactinomycin—ocular cancer	0.122	0.143	CbGbCtD
Sparfloxacin—TOP2A—G0 and Early G1—E2F5—ocular cancer	0.00682	0.0458	CbGpPWpGaD
Sparfloxacin—TOP2A—G0 and Early G1—E2F4—ocular cancer	0.00668	0.0448	CbGpPWpGaD
Sparfloxacin—TOP2A—G0 and Early G1—MYBL2—ocular cancer	0.00668	0.0448	CbGpPWpGaD
Sparfloxacin—TOP2A—G0 and Early G1—RBL1—ocular cancer	0.00655	0.044	CbGpPWpGaD
Sparfloxacin—TOP2A—G0 and Early G1—RBL2—ocular cancer	0.00601	0.0404	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 1—MYBL2—ocular cancer	0.00593	0.0398	CbGpPWpGaD
Sparfloxacin—TOP2A—G0 and Early G1—RBBP4—ocular cancer	0.00568	0.0381	CbGpPWpGaD
Sparfloxacin—TOP2A—G0 and Early G1—CDC25A—ocular cancer	0.0054	0.0363	CbGpPWpGaD
Sparfloxacin—TOP2A—G0 and Early G1—TFDP1—ocular cancer	0.00528	0.0355	CbGpPWpGaD
Sparfloxacin—TOP2A—G0 and Early G1—HDAC1—ocular cancer	0.00307	0.0206	CbGpPWpGaD
Sparfloxacin—TOP2A—G0 and Early G1—E2F1—ocular cancer	0.00252	0.0169	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.00241	0.0162	CbGpPWpGaD
Sparfloxacin—TOP2A—G0 and Early G1—CDK2—ocular cancer	0.00218	0.0146	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2C—ocular cancer	0.00213	0.0143	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.00209	0.0141	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.00209	0.0141	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.00199	0.0134	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.00195	0.0131	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—E2F5—ocular cancer	0.00177	0.0119	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.00176	0.0119	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—E2F4—ocular cancer	0.00173	0.0116	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—MYBL2—ocular cancer	0.00173	0.0116	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—E2F2—ocular cancer	0.0017	0.0114	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—RBL1—ocular cancer	0.0017	0.0114	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—RBL2—ocular cancer	0.00156	0.0105	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—CRTC1—ocular cancer	0.00155	0.0104	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—E2F3—ocular cancer	0.00147	0.00989	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—RBBP4—ocular cancer	0.00147	0.00989	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDC25A—ocular cancer	0.0014	0.00941	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—ID2—ocular cancer	0.00138	0.00925	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—TFDP1—ocular cancer	0.00137	0.0092	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.00131	0.00883	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00131	0.00882	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00129	0.00865	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND3—ocular cancer	0.00124	0.00834	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.00113	0.00759	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.00111	0.00743	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.00093	0.00625	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDK6—ocular cancer	0.000925	0.00621	CbGpPWpGaD
Sparfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—ocular cancer	0.00092	0.00618	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.00092	0.00618	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—MYC—ocular cancer	0.000897	0.00602	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.000802	0.00539	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.000796	0.00534	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.000796	0.00534	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.000779	0.00524	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.000758	0.00509	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—TP53—ocular cancer	0.000736	0.00495	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.000713	0.00479	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN2C—ocular cancer	0.000697	0.00468	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—GNA11—ocular cancer	0.00069	0.00464	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.000685	0.0046	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.000659	0.00443	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.000655	0.0044	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—E2F5—ocular cancer	0.000649	0.00436	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—GNAQ—ocular cancer	0.000642	0.00431	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.000635	0.00427	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—E2F4—ocular cancer	0.000635	0.00427	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—RBL1—ocular cancer	0.000623	0.00419	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—E2F2—ocular cancer	0.000623	0.00419	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—E2F5—ocular cancer	0.00058	0.0039	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—HDAC1—ocular cancer	0.000579	0.00389	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—RBL2—ocular cancer	0.000572	0.00384	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—E2F4—ocular cancer	0.000568	0.00382	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MYBL2—ocular cancer	0.000568	0.00382	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.000565	0.00379	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.000562	0.00378	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—E2F2—ocular cancer	0.000557	0.00374	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—RBL1—ocular cancer	0.000557	0.00374	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00054	0.00363	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00054	0.00363	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00054	0.00363	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.000534	0.00358	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.000514	0.00345	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000513	0.00345	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—RBL2—ocular cancer	0.000512	0.00344	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.000502	0.00337	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000496	0.00333	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.00049	0.00329	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—E2F3—ocular cancer	0.000483	0.00324	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—RBBP4—ocular cancer	0.000483	0.00324	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.000474	0.00318	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—ocular cancer	0.000464	0.00312	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDC25A—ocular cancer	0.00046	0.00309	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND3—ocular cancer	0.000455	0.00306	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TFDP1—ocular cancer	0.000449	0.00302	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.000432	0.0029	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000428	0.00287	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.000424	0.00285	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND3—ocular cancer	0.000407	0.00273	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000404	0.00272	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000393	0.00264	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—CDK4—ocular cancer	0.000388	0.00261	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000361	0.00243	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000345	0.00231	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000339	0.00228	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000333	0.00224	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000323	0.00217	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDK6—ocular cancer	0.000303	0.00204	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.0003	0.00201	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000292	0.00196	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000292	0.00196	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000276	0.00186	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000274	0.00184	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000268	0.0018	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000262	0.00176	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000261	0.00175	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND2—ocular cancer	0.000261	0.00175	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—HDAC1—ocular cancer	0.000261	0.00175	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000253	0.0017	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00024	0.00161	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—E2F1—ocular cancer	0.00024	0.00161	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN2B—ocular cancer	0.000234	0.00157	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—EP300—ocular cancer	0.000231	0.00155	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—E2F1—ocular cancer	0.000215	0.00144	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000209	0.00141	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000209	0.0014	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000207	0.00139	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000205	0.00138	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000196	0.00131	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDK2—ocular cancer	0.000185	0.00124	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000185	0.00124	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—TGFB1—ocular cancer	0.000181	0.00122	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000178	0.00119	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDK4—ocular cancer	0.000175	0.00118	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000172	0.00115	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—RB1—ocular cancer	0.00017	0.00114	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—TP53—ocular cancer	0.000165	0.00111	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000163	0.0011	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—RB1—ocular cancer	0.000152	0.00102	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000145	0.000975	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000141	0.000946	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PSPH—ocular cancer	0.00014	0.00094	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000139	0.000936	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000133	0.000894	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000132	0.00089	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MDM2—ocular cancer	0.00013	0.000871	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000126	0.000849	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000122	0.000821	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN1B—ocular cancer	0.000118	0.000796	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—EP300—ocular cancer	0.000116	0.000781	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND1—ocular cancer	0.000113	0.000759	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000112	0.000751	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN1A—ocular cancer	0.000109	0.000734	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—EP300—ocular cancer	0.000104	0.000699	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—ocular cancer	0.000101	0.000681	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	9.87e-05	0.000663	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MYC—ocular cancer	9.06e-05	0.000609	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	9.01e-05	0.000605	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	8.6e-05	0.000577	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	8.31e-05	0.000558	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	7.91e-05	0.000531	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TP53—ocular cancer	7.44e-05	0.0005	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	6.89e-05	0.000463	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	6.88e-05	0.000462	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	5.66e-05	0.00038	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	4.78e-05	0.000321	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GNA11—ocular cancer	4.4e-05	0.000296	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GNAQ—ocular cancer	4.09e-05	0.000275	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—EP300—ocular cancer	1.47e-05	9.88e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AKT1—ocular cancer	8.89e-06	5.97e-05	CbGpPWpGaD
